Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Achromobacter xylosoxidans as emerging pathogen in healthcare settings: A mini review
View through CrossRef
Microorganisms of the genus Achromobacter have been mentioned as a cause of opportunistic infections, mainly in patients with cystic fibrosis or pulmonary lymphoma, with the species Achromobacter xylosoxidans being identified to a large extent. A. xylosoxidans was first described in 1971 and is an opportunistic pathogen. However, it been reported to cause chronic purulent otitis, meningitis, pneumonia, peritonitis and urinary tract infections, chronic obstructive pulmonary disease and other infections. The present literature review aims to analyze and synthesize the state of the art on A. xylosoxidans and its potential as an emerging pathogen in the healthcare settings. We discuss A. xylosoxidans as an emerging opportunistic pathogen that is associated with healthcare infections. This review further discusses the prevalence of A. xylosoxidans in healthcare settings, the types of infections it can cause, and the risk factors for acquiring an A. xylosoxidans infection. The review also covers the challenges in treating A. xylosoxidans infections, including its potential for drug resistance and the lack of specific treatments. Strategies for preventing and controlling A. xylosoxidans infections in healthcare settings were also discussed.
Title: Achromobacter xylosoxidans as emerging pathogen in healthcare settings: A mini review
Description:
Microorganisms of the genus Achromobacter have been mentioned as a cause of opportunistic infections, mainly in patients with cystic fibrosis or pulmonary lymphoma, with the species Achromobacter xylosoxidans being identified to a large extent.
A.
xylosoxidans was first described in 1971 and is an opportunistic pathogen.
However, it been reported to cause chronic purulent otitis, meningitis, pneumonia, peritonitis and urinary tract infections, chronic obstructive pulmonary disease and other infections.
The present literature review aims to analyze and synthesize the state of the art on A.
xylosoxidans and its potential as an emerging pathogen in the healthcare settings.
We discuss A.
xylosoxidans as an emerging opportunistic pathogen that is associated with healthcare infections.
This review further discusses the prevalence of A.
xylosoxidans in healthcare settings, the types of infections it can cause, and the risk factors for acquiring an A.
xylosoxidans infection.
The review also covers the challenges in treating A.
xylosoxidans infections, including its potential for drug resistance and the lack of specific treatments.
Strategies for preventing and controlling A.
xylosoxidans infections in healthcare settings were also discussed.
Related Results
Prevalence and variability of siderophore production in the
Achromobacter
genus
Prevalence and variability of siderophore production in the
Achromobacter
genus
ABSTRACT
Achromobacter
spp. are opportunistic pathogens of environmental origin increasingly isolated in patients w...
Achromobacter xylosoxidans
modulates
Pseudomonas aeruginosa
virulence through a multi-target mechanism of competition
Achromobacter xylosoxidans
modulates
Pseudomonas aeruginosa
virulence through a multi-target mechanism of competition
ABSTRACT
The colonization and persistence of
Pseudomonas aeruginosa
in chronically diseased lungs are driven ...
Perceptions of Telemedicine and Rural Healthcare Access in a Developing Country: A Case Study of Bayelsa State, Nigeria
Perceptions of Telemedicine and Rural Healthcare Access in a Developing Country: A Case Study of Bayelsa State, Nigeria
Abstract
Introduction
Telemedicine is the remote delivery of healthcare services using information and communication technologies and has gained global recognition as a solution to...
Achromobacter species, an emerging cause of bacteremia in tertiary healthcare facilities in Egypt
Achromobacter species, an emerging cause of bacteremia in tertiary healthcare facilities in Egypt
During our laboratory routine, we detected Gram-negative, motile, aerobic, oxidase- and catalase-positive, lactose non-fermenting bacilli during microbial isolation from blood cult...
1711. In Vitro Activity of Cefiderocol Against US Achromobacter spp. and Burkholderia spp. Clinical Isolates from the SENTRY Surveillance Program 2020-2021
1711. In Vitro Activity of Cefiderocol Against US Achromobacter spp. and Burkholderia spp. Clinical Isolates from the SENTRY Surveillance Program 2020-2021
Abstract
Background
Infections caused by Achromobacter spp. and Burkholderia spp. have limited clinical treatment options due to...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical activi...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Achromobacter pneumonia in a patient with advanced COPD, a diagnostic challenge
Achromobacter pneumonia in a patient with advanced COPD, a diagnostic challenge
Bacterial pneumonia causes significant morbidity and mortality especially in elderly and immunocompromised hosts. Achromobacter xylosoxidans denitrificans pneumonia is very rarely ...